Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- New Onset Type 1 Diabetes: Role of Exenatide: Complete Statistical AnalysisIndependent statistical analysis of New Onset Type 1 Diabetes: Role of Exenatide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01269034).
- New Treatment for Alcohol and Nicotine Dependence: Complete Statistical AnalysisIndependent statistical analysis of New Treatment for Alcohol and Nicotine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182766).
- NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait (Biomechanical Adaptations): Complete Statistical AnalysisIndependent statistical analysis of NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait (Biomechanical Adaptations): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NEwTON AFIndependent statistical analysis of Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NEXT2Independent statistical analysis of Efficacy of Esomeprazole in Patients With Frequent Heartburn: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01370538).
- NEXUSIndependent statistical analysis of Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- NFPIndependent statistical analysis of Nurse-Family Partnership Impact Evaluation in South Carolina: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03360539).
- NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation: Complete Statistical AnalysisIndependent statistical analysis of NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation: primary endpoint results, effect estimate…
- NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03929913).
- NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial: Complete Statistical AnalysisIndependent statistical analysis of NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NIA-SCOREIndependent statistical analysis of NeuroCognition After Carotid Recanalization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04219774).
- Niacin and Endothelial Function in Early CKD: Complete Statistical AnalysisIndependent statistical analysis of Niacin and Endothelial Function in Early CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00852969).
- NICEIndependent statistical analysis of Neurogenic Intermittent Claudication Evaluation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00905359).
- NICHEIndependent statistical analysis of N-of-1 Trials In Children With Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03461003).
- NICHEIndependent statistical analysis of Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02089464).
- Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging: Complete Statistical AnalysisIndependent statistical analysis of Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01664741).
- Nicotine Lozenge Bioequivalence Study: Complete Statistical AnalysisIndependent statistical analysis of Nicotine Lozenge Bioequivalence Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01536704).
- Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L: Complete Statistical AnalysisIndependent statistical analysis of Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532374).
- Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol): Complete Statistical AnalysisIndependent statistical analysis of Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol).: Complete Statistical AnalysisIndependent statistical analysis of Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Nicotine Pharmacokinetics of THS Single Use of a Regular or a Menthol Stick Compared to CIG: Complete Statistical AnalysisIndependent statistical analysis of Nicotine Pharmacokinetics of THS Single Use of a Regular or a Menthol Stick Compared to CIG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment: Complete Statistical AnalysisIndependent statistical analysis of Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nicotine Reinforcement and Aversion in Young Adult Light Smokers: Complete Statistical AnalysisIndependent statistical analysis of Nicotine Reinforcement and Aversion in Young Adult Light Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01495819).
- Nicotine Withdrawal Symptoms and Smoking Relapse: Complete Statistical AnalysisIndependent statistical analysis of Nicotine Withdrawal Symptoms and Smoking Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01511614).
- Nicotine’s Potential Abuse With Menthol: Complete Statistical AnalysisIndependent statistical analysis of Nicotine's Potential Abuse With Menthol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04535362).
- Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02069392).
- NICU-TECH RM9L-RS Probe ME Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of NICU-TECH RM9L-RS Probe ME Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01181596).
- NIH_HVX6Independent statistical analysis of Chewing and Oral Processing of Solid Food: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05594173).
- NIKAIA 1Independent statistical analysis of To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus: primary endpoint results, effect estimate…
- NILOdeepRIndependent statistical analysis of Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor: Complete Statistical AnalysisIndependent statistical analysis of Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR): Complete Statistical AnalysisIndependent statistical analysis of Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of…
- NIMBUSIndependent statistical analysis of A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple…
- NIMBUSIndependent statistical analysis of A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1): Complete Statistical AnalysisIndependent statistical analysis of Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NIPUTFDIndependent statistical analysis of Neuroimaging in Patients Undergoing TMS for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02974296).
- NIRAFIndependent statistical analysis of Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Niraparib + Dostarlimab + RT in Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Niraparib + Dostarlimab + RT in Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04409002).
- Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- NIRVANAIndependent statistical analysis of Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03220230).
- NIRVANAIndependent statistical analysis of Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04818216).
- NIRVANAIndependent statistical analysis of Study to Evaluate Effect of Nebivolol on Angina in Women With Microvascular Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Nitrate Supplementation and Exercise Tolerance in Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Nitrate Supplementation and Exercise Tolerance in Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete’s Foot: Complete Statistical AnalysisIndependent statistical analysis of Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02871011).
- Nitroglycerin Infusion During Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nitroglycerin Infusion During Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01901419).
- Nitrous Oxide for External Cephalic Version: Complete Statistical AnalysisIndependent statistical analysis of Nitrous Oxide for External Cephalic Version: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03502915).
- Nitrous Oxide for Identifying the Intersegmental Plane in Segmentectomy: A Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Nitrous Oxide for Identifying the Intersegmental Plane in Segmentectomy: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Nitrous Oxide Induction Induces Amnesia in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Nitrous Oxide Induction Induces Amnesia in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02050152).
- Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers: Complete Statistical AnalysisIndependent statistical analysis of Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers: primary endpoint results, effect estimate…